NIVF (NewGenIvf Group) EBIT per Share : $0.02 (TTM As of Dec. 2023)

View and export this data going back to 2024. Start your Free Trial

What is NewGenIvf Group EBIT per Share?

NewGenIvf Group's EBIT per Share for the six months ended in Dec. 2023 was $0.04. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.02.

During the past 12 months, the average EBIT per Share Growth Rate of NewGenIvf Group was -89.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for NewGenIvf Group's EBIT per Share or its related term are showing as below:

NIVF's 3-Year EBIT Growth Rate is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 8.25
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

NewGenIvf Group's EBIT for the six months ended in Dec. 2023 was $0.44 Mil.

NewGenIvf Group EBIT per Share Historical Data

The historical data trend for NewGenIvf Group's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NewGenIvf Group EBIT per Share Chart

NewGenIvf Group Annual Data

Trend

Dec21

Dec22

Dec23

EBIT per Share

0.02

0.04

0.02

NewGenIvf Group Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT per Share	-	0.10	-0.06	-0.03	0.04

NewGenIvf Group EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

NewGenIvf Group's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	0.155	/	10.149
=	0.02

NewGenIvf Group's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	0.439	/	10.149
=	0.04

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.02

NewGenIvf Group (NAS:NIVF) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

NewGenIvf Group EBIT per Share Related Terms

Thank you for viewing the detailed overview of NewGenIvf Group's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

NewGenIvf Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NewGenIvf Group Ltd (NAS:NIVF) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sukhumvit 21 Road, Asoke, 36/39-36/40, 13th Floor, PS Tower, Khlong Toei Nuea Sub-district, Watthana District, Bangkok, THA, 10110

Website

https://www.newgenivf.com

NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services.